Gilead Sciences - 2 Year Dividend History | GILD

Historical dividend payout and yield for Gilead Sciences (GILD) since 2017. The current TTM dividend payout for Gilead Sciences (GILD) as of June 19, 2019 is $2.52. The current dividend yield for Gilead Sciences as of June 19, 2019 is 3.69%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $86.948B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $110.770B 12.52
Bio-Techne Corp (TECH) United States $7.858B 53.62